Canngea

Sydney, Australia Founded: 2017 • Age: 9 yrs
Provides compliant distribution of medicinal cannabis to pharmacies and prescribers.

About Canngea

Canngea is a company based in Sydney (Australia) founded in 2017 by Colin Sergay and Martin Bryden. It operates as a B2B. The company has 653 employees. Canngea offers products and services including Pharmacy Ordering Portal and Prescribers Portal. Canngea operates in a competitive market with competitors including Cannaponics, THC Global Group, ESense-Lab, Elite Cannabinoids and SproutAI, among others.

Key Metrics
  • Annual Revenue
    ₹656 Cr

    FY 2025 · +19% YoY

  • Net Profit
    ₹74.14 Cr

    FY 2025 · 11% margin

  • EBITDA
    ₹198 Cr

    FY 2025 · 30% margin

  • Employee Count
    653

Products & Services of Canngea

Canngea offers a comprehensive portfolio of products and services, including Pharmacy Ordering Portal and Prescribers Portal.

Pharmacy Ordering Portal
Distribution Platform

Platform for pharmacies to order medicinal cannabis products compliantly.

Prescribers Portal
Information Service

Service providing guidelines and details on medicinal cannabis for prescribers.

Board of directors of Electronic Arts Games (India) Private Limited (Canngea)

Electronic Arts Games (India) Private Limited is the primary company behind Canngea. The board of Electronic Arts Games (India) Private Limited currently have 3 directors; the longest-serving is Priya Krishnadas, appointed in 2020. 16 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Priya Krishnadas
DIN 08760418
Managing Director02 Jul 20206 yrs 3 moElectronic Arts Games (India) Private Limited
Yong Soo Bae
DIN 09327082
Director09 Feb 20224 yrs 8 moElectronic Arts Games (India) Private Limited
James Larbey Crane
DIN 11202254
Director12 Sep 20251 yrElectronic Arts Games (India) Private Limited

People of Canngea

3 people are tracked at Canngea (3 in leadership); the tracked headcount is 653.

NameRoleGroup
Colin Sergay
Co-FounderLeadership
Martin Bryden
Co-Founder, CCOLeadership
Ryan Ballantyne
Managing DirectorLeadership
Premium access

Complete people profiles for Canngea

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Canngea

Figures of Electronic Arts Games (India) Private Limited, the primary company behind Canngea, for FY 2025. Revenue was ₹656 Cr (+19% year on year). Net profit was ₹74.14 Cr (11% margin). EBITDA was ₹198 Cr (30% margin). Revenue has grown at a compounded annual rate of +45% over three years and +37% over five years.

  • ₹656 CrRevenue · FY 2025 · +19% YoY
  • ₹74.14 CrNet profit · 11% margin
  • ₹198 CrEBITDA · 30% margin
  • ₹1.7 LakhPaid-up capital
  • 653Employees (provident fund records)
  • +45%Revenue CAGR, 3 years
  • +37%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Electronic Arts Games (India) Private Limited are on its company page.

Premium access

Detailed financial statements for Canngea

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of Canngea

Canngea operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cannaponics, THC Global Group, ESense-Lab, Elite Cannabinoids and SproutAI, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
cannaponics.com.au2019Perth, Australia$5.66M–
Medical cannabis products are cultivated and produced in Australia.
thc.global2016Sydney, Australia––
Medicinal cannabis products are cultivated, processed, and supplied vertically.
esense-lab.com2016Ness Ziona, Israel––
Terpene-based cannabis products are developed using genetic and analytical profiling.
elitecannabinoids.com.au2017Perth, Australia––
Cannabis crops are cultivated and processed for medicinal cannabinoid supply.
sproutai.solutions2018Arraijan, Panama––
Aeroponic vertical farms for cannabis cultivation are manufactured.
biortica.com2019Melbourne, Australia––
Vertically integrated B2B enterprise for medicinal plant cultivation and distribution.
hempfoods.com.au1999Bangalow, Australia––
Sells hemp seeds, oils, protein powders, and functional drinks online.
phuphanhemp.com2023Lindfield, Australia––
PhuPhan Hemp cultivates and produces high-quality hemp-based products.
rxmmhealth.com2015Perth, Australia––
Specializes in soil-less cannabis cultivation for medicinal product supply.
Premium access

Detailed competitors of Canngea

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Similar companies to Canngea

10 companies that operate in the same segment as Canngea (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Pharmaceutical products are manufactured and marketed worldwide.
1891Kenilworth, Warwickshire, United Kingdom–USD 64.93 B781
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United States–USD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United States–USD 61.16 B55,000
Traditional pharmaceutical medicines are developed for multiple health fields.
1876United States–USD 65.18 B47,000
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
1987Foster City, California, United States–USD 29.45 B17,600
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.
1993San Francisco, California, United StatesUSD 215.5 MUSD 29.62 M225
Developer of medical devices, generic pharmaceuticals, and nutrition products
1888Libertyville, Illinois, United States–USD 44.33 B3,710
Medicines and health products are retailed through pharmacy outlets.
2006Hyderabad, Telangana, IndiaUSD 268.78 MUSD 734.57 M25,010
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Canngea

Canngea was founded in 2017.

Canngea is headquartered in Sydney, Australia. It is registered at Sydney, New South Wales, Australia.

Canngea has 653 employees.

The primary company behind Canngea, Electronic Arts Games (India) Private Limited, reported revenue of β‚Ή656 Cr for FY 2025, up 19% year on year.

Canngea operates as a trusted pharmaceutical wholesaler specializing in medicinal cannabis products in Australia. They partner with pharmacies to ensure reliable and compliant supply through approved regulatory pathways. The company supports healthcare professionals with information on prescribing guidelines and requirements. Services include distribution, import, export, and supply chain management, all based in Brisbane, serving the medical community nationwide.

Canngea's top competitors include THC Global Group, ESense-Lab and Cannaponics.

Canngea offers Pharmacy Ordering Portal and Prescribers Portal.

Canngea operates through Electronic Arts Games (India) Private Limited.

The legal entities of Canngea currently have 3 directors, including Priya Krishnadas, Yong Soo Bae, James Larbey Crane.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available